Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease
Holly L. Geyer(Mayo Clinic Hospital), Jan Samuelsson(Karolinska University Hospital), Lydia Roy(Centre Hospitalier Universitaire de Poitiers), Jean‐Jacques Kiladjian(Délégation Paris 5), Francesco Passamonti(University of Milan), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Zhijian Xiao(Institute of Hematology & Blood Diseases Hospital), Gunnar Birgegård(Uppsala University Hospital), Jean‐Christophe Ianotto(Inserm), Xiujuan Sun(Chinese Academy of Sciences), Heike L. Pahl(University Medical Center Freiburg), Robyn M. Scherber(Blueprint Medicines (United States)), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Carlos Besses(Hospital Del Mar), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Andreas Reiter(Heidelberg University), Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Maria Luisa Ferrari(University of Bergamo), Harry C. Schouten, Norman Maldonado(University of Puerto Rico System), Heidi Kosiorek(Mayo Clinic in Florida), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Peter Johansson(Linköping University), Konstanze Döhner(University Hospital Ulm), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Peter A.W. te Boekhorst(Erasmus MC), Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tiziano Barbui(University of Bergamo), Gabriel Étienne(Institut Bergonié), Karin Bonatz(Centre Hospitalier Universitaire de Grenoble), Suzan Commandeur(Leiden University), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Sonja Zweegman(Vrije Universiteit Amsterdam), Robert Peter Gale(Imperial College London), Giovanni Barosi(Policlinico San Matteo Fondazione), Amylou C. Dueck(Mayo Clinic in Arizona), Yue Zhang(Guilin Medical University), Zefeng Xu(Henan University), Peihong Zhang(Tongji University), Junqing Xu(Shenzhen University), Jean‐Yves Cahn(Université Grenoble Alpes), Françoise Boyer(Centre Hospitalier Universitaire d'Angers), Zhenya Senyak, Ana Kerguelen Fuentes(Centre Hospitalier Universitaire de Grenoble), Martin Grießhammer(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie)
Cited by 65
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k